---
title: "NRXS.US (NRXS.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/NRXS.US/news.md"
symbol: "NRXS.US"
name: "NRXS.US"
parent: "https://longbridge.com/zh-CN/quote/NRXS.US.md"
datetime: "2026-03-15T16:08:47.364Z"
locales:
  - [en](https://longbridge.com/en/quote/NRXS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NRXS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NRXS.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/NRXS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NRXS.US/news.md)


# NRXS.US (NRXS.US) — 相关新闻

### [12 Health Care Stocks Moving In Monday's Intraday Session](https://longbridge.com/zh-CN/news/276628576.md)
*2026-02-23T17:05:36.000Z*
> In Monday's intraday session, Arcellx (ACLX) shares surged 77.6% to $113.83, while Vanda Pharmaceuticals (VNDA) rose 40.

### [NurExone Biologic Appoints Eyal Gabbai to Board Replacing Gadi Riesenfeld](https://longbridge.com/zh-CN/news/274418527.md)
*2026-02-01T10:41:25.000Z*
### [NurExone Adds Healthcare Heavyweight Eyal Gabbai to Board as It Advances Exosome Platform](https://longbridge.com/zh-CN/news/274360961.md)
*2026-01-30T21:58:04.000Z*
> NurExone Biologic has appointed Eyal Gabbai to its board of directors, replacing Gadi Riesenfeld, who will remain on the

### [NurExone Biologic Appoints Eyal Gabbai to Board](https://longbridge.com/zh-CN/news/274356149.md)
*2026-01-30T21:03:11.000Z*
### [NeurAxis Inc. to Present at Lytham Partners Healthcare Investor Summit](https://longbridge.com/zh-CN/news/271935823.md)
*2026-01-08T13:00:13.000Z*
### [Abeona Therapeutics CEO Vishwas Seshadri Reports Sale of Common Shares](https://longbridge.com/zh-CN/news/271031833.md)
*2025-12-29T21:30:51.000Z*
### [](https://longbridge.com/zh-CN/news/270524919.md)
*2025-12-22T18:11:09.000Z*
> Neuraxis shares are trading higher after Craig-Hallum maintained the stock with a Buy rating and raised the price target

### [](https://longbridge.com/zh-CN/news/270326638.md)
*2025-12-19T14:17:22.000Z*
> NeurAxis shares are trading higher after the company announced new medical policy coverage from a national health insure

### [NeurAxis, Inc. Reports Increased Sales Amidst Ongoing Losses](https://longbridge.com/zh-CN/news/265438390.md)
*2025-11-12T04:11:15.000Z*
> NeurAxis, Inc. (NRXS) reported Q3 earnings with net sales increasing to $811,414 from $666,625 year-over-year. However,